Astragaloside IV sensitizes non–small cell lung cancer cells to gefitinib potentially via regulation of SIRT6
Astragaloside IV, the active component of Astragalus membranaceus , exhibits diverse biological roles including the anti-tumor activity. In this study, we evaluated the chemosensitive role of astragaloside IV in non–small cell lung cancer cells. Cell Counting Kit-8 analysis was performed to determin...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IOS Press
2017-04-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317697555 |